BioCentury | Apr 6, 2021
Finance
VCs led by HBM, Samsara back single-asset Mitsubishi Tanabe spinout Mineralys with $40M for hypertension program
...pressure, will be due in 2H22.Mineralys’ founder and chairman is Managing Partner BT Slingsby of Catalys Pacific...
...Healthcare Investments and Samsara BioCapital led the round, which also included Adams Street Partners and Catalys Pacific...
...NASDAQ:VRTX) as well as Novartis Institutes for Biomedical Research, where he was respiratory disease area translational medicine head.Catalys Pacific’s...
...Healthcare Investments and Samsara BioCapital led the round, which also included Adams Street Partners and Catalys Pacific...
...NASDAQ:VRTX) as well as Novartis Institutes for Biomedical Research, where he was respiratory disease area translational medicine head.Catalys Pacific’s...
